Efficacy and safety of add-on tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate.

Tae-Jong KimHan Joo BaekYoung Mo KangHoon-Suk ChaSeong Wook KangSung-Hwan ParkJae Bum JunYun Jong LeeIn Ah Choi Yeong-Wook Song

Published in: International journal of rheumatic diseases (2019)

The efficacy of TAC combined with MTX was non-inferior to LEF + MTX. It had a reasonable safety profile in RA patients with moderate to severe disease activity (http://cris.nih.go.kr; KCT0000781).

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
high dose
early onset
high intensity
interstitial lung disease
low dose
idiopathic pulmonary fibrosis